T. Willigenburg
Papers
1
Total Citations
21
H-Index
1
About
T. Willigenburg is a pioneering researcher in urological oncology, with a primary focus on patient-reported outcomes and innovative clinical trial methodologies for prostate cancer. Their most notable contribution is the development and implementation of the Utrecht Prostate Cohort (UPC), the first "trials within cohorts" (TwiCs) platform specifically designed for prostate cancer research. This groundbreaking framework allows for the efficient evaluation of interventions by embedding randomized trials within an ongoing observational cohort, significantly streamlining the research process. Their landmark 2022 paper describing the UPC has already garnered 21 citations, reflecting its immediate impact on the field. By prioritizing patient-reported outcomes, Willigenburg ensures that the patient's voice is central to evaluating treatment effectiveness and quality of life. This work represents a major methodological advancement, offering a more pragmatic, cost-effective, and patient-centered approach to conducting clinical trials in prostate cancer, with the potential to reshape how interventions are tested and implemented in routine care.
Research Focus
Key Achievements
Top Papers
- 1